Algo version: 0.98b
MDGL is listed at the NASDAQ Exchange
MDGL [MDGL]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is MDGL stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Madrigal Pharmaceuticals 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $140.35, you would have made a profit of $103.62 per share or 73.83%

Yes, the average daily trading liquidity for Madrigal Pharmaceuticals is $97.11 million. You should therefore be able to get in and out of your positions relatively fast.

Madrigal Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Madrigal Pharmaceuticals to be high [0.75 out of 1]